Veralto Corp H1 2026: Revenue Falls, Margins Rise, Funding Needed Fast
Veralto’s H1 2026 results reveal a sharp revenue dip, but higher‑margin consumables and a growing pathogen‑detection pipeline offer upside—don’t miss this deep dive.
5 minutes to read









